Award Data

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is a significant advance in the production of hydrogen peroxide. It is anticipated that this project will yield an on-site generation method that substantially reduces the cost of peroxide production compared to the traditional centralized chemical process. By reducing cost, hydrogen peroxide can be u ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to reduce the cost and increase the quality and throughput of mass spectrometry research through the development of advanced analytical software. Biomedical, biotech, agricultural, and chemical companies spend an estimated $15B per year on mass spectrometry because of the commercial value ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to help usher in a new age of material consumption. While metals have been used for hundreds of years, composites are fairly new but can withstand even more wear and tear than steel. This project is aimed to advance composites even further by making them last longer or shed more weight. Th ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is the realization of a next-generation soft tissue filler. Fillers are used to replenish volumes left by surgical procedures, medical disorders, trauma, or aging. In this $6B global market, there is great need for a filler having superior longevity to the leading hyaluronic acid products, wh ...

This SBIR Phase II project aims to develop an external stent to improve the quality and length of life for dialysis patients. Dialysis is the primary lifeline for patients with failed kidneys (i.e. End-Stage Renal Disease (ESRD)). Unfortunately, our current standard of care, which provides no additional support or treatment to the artery-vein connections surgically created in the arm to initiate d ...

This STTR Phase 2 project is aimed at providing technology to address the high costs of developing effective and safe drugs. Bringing a new drug to market typically involves screening 100's of thousands of compounds for efficacy and toxicity utilizing cell, tissue and animal models to ultimately select a lead compound that will be tested in clinical trials. This process can take years, billions of ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project further investigates music-based techniques that can result in effective and efficient learning and instruction. Music as a bedrock of culture can transcend entertainment and enhance learning. Music directly activates neural systems that support memory, attention, motivation, and emotion. Acc ...

This SBIR Phase II project will enable the development of the first known commercial medical ultrasound device utilizing air-coupled Capacitive Micromachine Ultrasound Transducer (CMUT) technology to diagnose otitis media. Otitis media is the number one indication for which antibiotics are prescribed for children, and the number one cause for surgery in childhood, costing $15+B annually in the US ...

The increasing complexity of devices, reduced budgets and accelerated program timelines, requires a new approach to predicting radiation of integrated circuit (IC) designs. Most approaches to date require gate level analysis and do not scale easily to device level calculations, leading to methods that are note practical under most program timeline and cost budgets. Previously, DfR Solutions has de ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project lies ultimately in saving lives. This project proposes a Machine Learning-enabled Internet of Things (IoT) firearms detection system for law enforcement. Implementation of this technology would significantly reduce the cognitive burden of police officers in dangerous situations, allowing for ...